[{"Assets_0_FY_USD":601585000.0,"CommonStockSharesOutstanding_0_FY_shares":20909301.0,"EarningsPerShareBasic_1_FY_USD":0.15,"EarningsPerShareBasic_4_FY_USD":-0.08,"EarningsPerShareDiluted_1_FY_USD":0.15,"EarningsPerShareDiluted_4_FY_USD":-0.08,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":63001000.0,"NetIncomeLoss_1_FY_USD":-3125000.0,"NetIncomeLoss_4_FY_USD":-1636000.0,"StockholdersEquity_0_FY_USD":341290000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_FY_shares":20898000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":20831000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_FY_shares":20898000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":20831000.0,"Ticker":"LGND","CIK":"886163","name":"LIGAND PHARMACEUTICALS INC","OfficialName":"Ligand Pharmaceuticals Incorporated Common Stock","form":"10-K","period":"20161231","fy":"2016.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1738856427.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170228"}]